Publications

Publications

320 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Conditional inclusion procedure for medicinal products

This document describes the conditional inclusion procedure for orphan drugs, conditionals and exceptionals.

Publication | 30-07-2020

Ibrutinib (Imbruvica®) for the treatment of Waldenstrom's disease

Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...

Report | 03-07-2020

Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)

Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...

Report | 03-07-2020

GVS assessment of Trifarotene (50 microgram/gram cream) (Aklief®) for the cutaneous treatment of acne vulgaris on the face and torso in patients aged 12 years and over

Zorginstituut Nederland has completed its assessment whether trifarotene (50 microgram/gram cream) (Aklief®) for the cutaneous ...

Report | 11-06-2020

Package advice dabrafenib/trametinib (Tafinlar®/Mekinist®)

Zorginstituut Nederland has completed its reassessment of the pharmaco-economic analysis of dabrafenib in combination with ...

Report | 02-06-2020

International strategic agenda 2020 National Health Care Institute

When performing its tasks, the National Health Care Institute (Zorginstituut Nederland, or ZIN) participates with various other ...

Publication | 30-05-2020

Oral semaglutide (Rybelsus®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus

Zorginstituut Nederland has completed its assessment whether oral semaglutide (Rybelsus®) is interchangeable with a product that ...

Report | 29-05-2020

Specialist medicinal products assessment procedure

Zorginstituut Nederland only assesses specialist medicinal products that pose a risk to the accessibility, affordability or ...

Report | 11-05-2020

Pentosan polysulfate sodium (Elmiron®) for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions

Zorginstituut Nederland has completed its assessment whether pentosan polysulfate sodium (Elmiron®) is interchangeable with a ...

Report | 28-04-2020

12 SQ-HDM SLIT (Itulazax®) for the treatment of allergic rhinitis or conjunctivitis induced by pollen from the birch homologous group

Zorginstituut Nederland has completed its assessment whether 12 SQ-HDM SLIT (Itulazax®) is interchangeable with a product that ...

Report | 28-04-2020